|
1 Indications And Usage Tukysa Is Indicated In Combination With Trastuzumab And Capecitabine For Treatment Of Adult Patients With Advanced Unresectable Or Metastatic Her2-Positive Breast Cancer, Including Patients With Brain Metastases, Who Have Received One Or More Prior Anti-Her2-Based Regimens In The Metastatic Setting. Tukysa Is A Kinase Inhibitor Indicated In Combination With Trastuzumab And Capecitabine For Treatment Of Adult Patients With Advanced Unresectable Or Metastatic Her2-Positive Breast Cancer, Including Patients With Brain Metastases, Who Have Received One Or More Prior Anti-Her2-Based Regimens In The Metastatic Setting. ( 1 )
|